Prometheus Biosciences, Inc. — Form D

Prometheus Biosciences, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-15. The offering totals $50.0M, of which $20.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (43)

Showing 25 of 43 people.

NameRoleLocation
GREGORY L BEHARDirectorSAN DIEGO, CA
Scott L GlennDirectorBoulder, CO
SHLOMO T MELMEDDirectorSAN DIEGO, CA
Gerald T ProehlDirectorLa Jolla, CA
WILLIAM F SANDBORN, M.D.DirectorSAN DIEGO, CA
MARK T STENHOUSEDirectorSAN DIEGO, CA
Douglas F WallDirectorRancho Santa Fe, CA
SHIERLEY T WIDJAJADirectorSAN DIEGO, CA
TADATAKA T YAMADA, M.D.DirectorSAN DIEGO, CA
Scott L GlennExecutive OfficerBoulder, CO
Lauren OtsukiExecutive OfficerSan Diego, CA
Shierley WidjajaDirectorSan Diego, CA
James LaurDirectorRaleigh, NC
Douglas WallDirectorPoway, CA
Shlomo MelmedDirectorSan Jose, CA
Tadataka Yamada, M.D.DirectorSeattle, WA
Joy Ghosh, Ph.D.DirectorSan Diego, CA
Martin Hendrix, Ph.D.DirectorSan Diego, CA
James D LaurDirectorSan Diego, CA
Joseph C PapaDirectorSan Diego, CA
William C Sandborn, M.D.DirectorSan Diego, CA
Adam C StoneDirectorSan Diego, CA
Shierley C WidjajaDirectorSan Diego, CA
Tadataka Tachi Yamada, M.D.DirectorSan Diego, CA
Mark Tachi McKennaDirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2020-11-12D$130.0M$50.0M
2020-04-10D/A$60.0M$48.1M
2018-11-28D$20.0M$10.1M
2017-10-10D$10.0M$3.7M

More